Live Breaking News & Updates on Stevend Skolsky

Stay updated with breaking news from Stevend skolsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Basilea Pharmaceutica : Minutes_EN | MarketScreener

English translation of the German original minutes

Minutes of the 22nd Annual General Meeting of Basilea Pharmaceutica Ltd ,

held on April. | May 4, 2023 ....

Domenico Scala , Stevend Skolsky , Damian Heller , Caroline Cron , Martin Nicklasson , Thomas Werner , Peter Ulli , Daniel Anliker , David Veitch , Leonard Kruimer , Yves Ackermann , Andrea Schmutz , Meeting Of Basilea Pharmaceutica Ltd , Pricewaterhousecoopers Ltd , Annual General Meeting , Basilea Pharmaceutica Ltd , Corporate Secretary , Independent Proxy , General Meeting April , Innovation Park Basel Area Main , Chief Executive Officer , Swiss Official Gazette , Carole Sable , Basilea Pharmaceutica Ag Stock Exchange , Press Release , N Bsln Ch0011432447 ,

Basilea Pharmaceutica AG: Basilea shareholders approve all proposals of the board of directors at the annual general meeting

Press Release Basel, Switzerland, April 13, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that shareholders approved all proposals of the board of directors at today's annual general ....

Basel Stadt , Nils Schr , Caroline Cron , Nicole Onetto , Thomas Werner , Martin Nicklasson , Domenico Scala , Stevend Skolsky , Leonard Kruimer , Articles Of Association , Head Of Corporate Communications Investor Relations , Compensation Committee , Swiss Exchange , Basilea Pharmaceutica Ltd , Audit Committee , Management Committee , Pricewaterhousecoopers Ltd , Swiss Federal Council , Basilea Pharmaceutica , Corporate Communications ,

Investegate |Basilea Pharmaceutica AG Announcements | Basilea Pharmaceutica AG: Basilea shareholders approve all proposals of the board of directors at the annual general meeting

Investegate announcements from Basilea Pharmaceutica AG, Basilea shareholders approve all proposals of the board of directors at the annual general meeting ....

Basel Stadt , Nils Schr , Caroline Cron , Nicole Onetto , Thomas Werner , Martin Nicklasson , Domenico Scala , Stevend Skolsky , Leonard Kruimer , Articles Of Association , Head Of Corporate Communications Investor Relations , Compensation Committee , Swiss Exchange , Basilea Pharmaceutica Ltd , Audit Committee , Management Committee , Pricewaterhousecoopers Ltd , Swiss Federal Council , Basilea Pharmaceutica , Corporate Communications , Investor Relations , Investegate Announcements , Investegate Company Announcements , Basilea Pharmaceutica Ag , Lobenewswire And Globenewswire ,

Basilea to become a leading anti-infectives company backed

65% year-on-year growth in non-deferred revenue from Cresemba and Zevtera Operating profit of CHF 1.2 million Future strategic focus on anti-infectives. ....

Basel Stadt , Asahi Kasei Pharma , David Veitch , Nicole Onetto , Thomas Werner , Cresemba Zevtera , Martin Nicklasson , Domenico Scala , Leonard Kruimer , Stevend Skolsky , Adesh Kaul , National Medical Products Administration , Basilea Pharmaceutica Ltd , Chief Executive Officer , Chief Financial Officer , Basilea Pharmaceutica , Drug Approval Licenses , Drug Evaluation , New Drug Application , Swiss Stock Exchange Bsln , Basilea Pharmaceutica Ag ,

Basilea Pharmaceutica AG: Basilea to become a leading anti-infectives company backed by strong financial results 2021

65% year-on-year growth in non-deferred revenue from Cresemba and Zevtera Operating profit of CHF 1.2 million Future strategic focus on anti-infectives Exploring strategic options to maximize the value ....

United States , Basel Stadt , Nils Schr , Asahi Kasei Pharma , David Veitch , Nicole Onetto , Thomas Werner , Domenico Scala , Cresemba Zevtera , Martin Nicklasson , Leonard Kruimer , Adesh Kaul , Stevend Skolsky , Head Of Corporate Communications Investor Relations , Arqule Inc , Merck Co Inc , Biomedical Advanced Research , Human Services , Us Department Of Health , Drug Administration , Development Authority , Swiss Exchange , Basilea Pharmaceutica Ltd , Germany Federal Ministry Of Education , Office Of The , National Medical Products Administration ,